A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

@article{Hatzimouratidis2014ARO,
  title={A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.},
  author={Konstantinos Hatzimouratidis},
  journal={Therapeutic advances in urology},
  year={2014},
  volume={6 4},
  pages={
          135-47
        }
}
Epidemiological data link erectile dysfunction (ED) and benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS), two highly prevalent conditions in aging men, assuming common pathophysiological pathways. Tadalafil 5 mg once daily has been approved for the treatment of men with LUTS with or without comorbid ED. The aim of this review is to provide an overview of current knowledge on the epidemiological and pathophysiological links between ED and LUTS and to focus on… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 70 REFERENCES

Similar Papers

Loading similar papers…